By Mill Chart
Last update: Mar 5, 2024
In this article we will dive into ABBOTT LABORATORIES (NYSE:ABT) as a possible candidate for quality investing. Investors should always do their own research, but we noticed ABBOTT LABORATORIES showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.
As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.
Taking everything into account, ABT scores 7 out of 10 in our fundamental rating. ABT was compared to 196 industry peers in the Health Care Equipment & Supplies industry. ABT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABT is not valued too expensively and it also shows a decent growth rate.
For an up to date full fundamental analysis you can check the fundamental report of ABT
More quality stocks can be found in our Caviar Cruise screen.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
ABBOTT LABORATORIES
NYSE:ABT (4/26/2024, 4:37:29 PM)
After market: 107.74 +0.21 (+0.2%)107.53
+0.67 (+0.63%)
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.
The Nasdaq and S&P 500 tumbled below their 50-day lines.
ABT earnings call for the period ending March 31, 2024.
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Abbott Laboratories (NYSE:ABT) just reported results for the first quarter of 2...
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but shares fell.